Table 2.
Sample prevalence Number (percent) |
Population estimate Percent (standard error) |
|
---|---|---|
Lifetime overdose among total sample (n = 539) | 234 (43.4%) | 46.6% (±14.6) |
Age at first overdose Mean (standard deviation) |
20.4 (3.4) | – |
Number of overdoses (n = 233, 1 participant missing data) | ||
1 | 96 (41.2%) | 38.9% (±11.8) |
2–3 | 76 (32.6%) | 39.6% (±11.5) |
4 or more | 61 (26.2%) | 21.5% (±9.1) |
Number of substances used at last overdose (n = 233, 1 participant missing data) | ||
1 | 85 (36.5%) | 41.1% (±11.4) |
2 | 85 (36.5%) | 37.3% (±11.4) |
3 or more | 63 (27.0%) | 21.6% (±10.5) |
Opioid(s) used at last overdose (n = 234) | ||
Heroin only | 162 (69.2%) | 75.8% (±9.6) |
PO only | 28 (12.0%) | 10.7% (±8.3) |
Heroin and PO | 19 (8.1%) | 5.8% (±4.5) |
No opioida | 25 (10.7%) | 7.6% (±3.4) |
Route of heroin administration at last overdose (among the 181 who used heroin at last overdose, n = 178, 3 pts. missing data) | ||
Injected | 149 (83.7%) | 80.8% (±11.8) |
Snorted/sniffed | 29 (16.3%) | 19.2% (±11.8) |
Smoked | 0 (0%) | 0% (±0) |
Route of PO administration at last overdose b | ||
Injected | 5 (17.2%) | 7.4% (±9.0) |
Snorted/sniffed | 5 (17.2%) | 11.7% (±18.5) |
Smoked | 1 (3.5%) | 9.1% (±29.6) |
Oral | 21 (72.4%) | 75.8% (±29.8) |
PO, prescription opioid.
Per the study’s operational definition of “overdose,” events that involved only non-opioid substances (e.g., alcohol, benzodiazepines, stimulants, etc.) were included, if they involved loss of consciousness and/or respiration or the person was unresponsive.
Percentages and population estimates total >100 because participants were able to report multiple routes.